(InSilico Medicine, Inc.) Insilico Medicine announced a research collaboration agreement with MAWI. The aim of the collaboration is to develop a range of multi-modal biomarkers of aging and mortality to help prevent the onset of cardiovascular diseases and extend human longevity.
from EurekAlert! - Technology, Engineering and Computer Science https://ift.tt/2OgDg02
Saturday, September 29, 2018
Clinical grade hardware and AI companies partner to develop biomarkers of aging
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment